Go to:
Logótipo
Você está em: Start > Publications > View > VASCULITIS AND RENOVASCULAR HYPERTENSION - A CASE REPORT
Map of Premises
Principal
Publication

VASCULITIS AND RENOVASCULAR HYPERTENSION - A CASE REPORT

Title
VASCULITIS AND RENOVASCULAR HYPERTENSION - A CASE REPORT
Type
Another Publication in an International Scientific Journal
Year
2022
Authors
Ferrão, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Matos, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ferreira, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tavares, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Nogueira Silva, L
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Lima, MJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Almeida, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
ISSN: 0263-6352
Indexing
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00W-XZ3
Resumo (PT):
Abstract (EN): OBJECTIVE: Vasculitides are a group of rare, systemic diseases that induce inflammatory reactions in blood vessels, causing a reduction of blood flow and ischemia. In the kidney, luminal narrowing reduces blood flow and activates the renin-angiotensin-aldosterone system, causing renovascular hypertension. DESIGN AND METHOD: Clinical case report. RESULTS: A 47-year-old male with previous intestinal tuberculosis and hypertension diagnosed two years prior (blood pressure around 220/110 mmHg) was referred to our Hypertension Clinic. He reported self-limited episodes of lumbar pain, tender erythematous nodules in the shins and arthralgias. His mean office blood pressure was 203/118 mmHg, confirmed in home blood pressure monitoring, without medication. He had left ventricular concentric hypertrophy and chronic kidney disease (eGFR 66 mL/min/1.73m2) with albuminuria (561 mg/24 h). Verapamil and clonidine were prescribed to search for secondary hypertension but he missed the following appointment. A few months later he was admitted to the Intensive Care Unit due to a hypertensive emergency, with acute kidney failure and a large peri-renal hematoma. A CT scan and an angiography showed bilateral renal scarring, intrarenal pseudoaneurysms and small irregularities in the renal arteries. The immunologic panel was negative. A PET scan showed a slight enhancement of the aorta walls and common carotid arteries and the diagnosis of large-vessel vasculitis was established. He was discharged with high-dose corticosteroids and lisinopril and returned to our Hypertension Clinic. His blood pressure remained uncontrolled despite full-dose amlodipine, chlorthalidone and nebivolol; lisinopril was stopped due to worsening kidney function. Due to doubts on the diagnosis, the CT scan was repeated, now showing also irregularities in the common hepatic artery and mesenteric artery, suggesting a medium-vessel vasculitis, namely polyarteritis nodosa, and cyclophosphamide was started. His blood pressure is now controlled with lisinopril 2.5 mg, amlodipine 10 mg bid, furosemide 40 mg bid, nebivolol 5 mg and clonidine 0,15 mg tid and his kidney function is stable. CONCLUSIONS: Renovascular hypertension is responsible for less than 1% of all cases of hypertension and, when present, it is usually caused by atherosclerotic disease or fibromuscular dysplasia. However, in more infrequent cases, an inflammatory systemic disease may be present and must be considered. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13 844 patients with hypertension (2014)
Another Publication in an International Scientific Journal
Roush, GC; Fagard, RH; Salles, GF; Pierdomenico, SD; Reboldi, G; Verdecchia, P; Eguchi, K; Kario, K; Hoshide, S; Polonia, J; de la Sierra, A; Hermida, RC; Dolan, E; Zamalloa, H
Letter on 'Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney' Reply (2013)
Another Publication in an International Scientific Journal
Quelhas Santos, J; Pestana M
Humanistic outcomes in hypertension research and practice (2006)
Another Publication in an International Scientific Journal
Schulz, RB; Rossignoli, P; Correr, CJ; Fernández Llimós, F
DEVELOPMENT OF A MOBILE HEALTH APP FOR THE MANAGEMENT OF HYPERTENSION, INCLUDING TREATMENT ADHERENCE ASSESSMENT, USING IMAGE DETECTION TECHNOLOGY – INSPIRERS-HTN (2021)
Another Publication in an International Scientific Journal
Nogueira-Silva, L; Vieira-Marques, P; Valente, J; Holtkötter, J; Amaral, R; Jácome, C; Ferreira, A; Almeida, R; Fonseca, JA

See all (56)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2025-07-06 at 02:39:11 | Acceptable Use Policy | Data Protection Policy | Complaint Portal